Pre-order Enquiry
Request Free Sample
Global Solid Tumor Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21748573 | Publishing Date : 21-Sep-2022 | No. of pages : 115
Detailed TOC of Global Solid Tumor Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market Segment by Application
1.3.1 Global Solid Tumor Drug Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Radiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Solid Tumor Drug Market Size (2017-2028)
2.1.1 Global Solid Tumor Drug Revenue (2017-2028)
2.1.2 Global Solid Tumor Drug Sales (2017-2028)
2.2 Global Solid Tumor Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Solid Tumor Drug Sales by Regions (2017-2022)
2.2.2 Global Solid Tumor Drug Revenue by Regions (2017-2022)
2.3 Global Solid Tumor Drug Market Size Forecast by Region
2.3.1 Global Solid Tumor Drug Sales Forecast by Region (2023-2028)
2.3.2 Global Solid Tumor Drug Revenue Forecast by Region (2023-2028)
2.4 Global Top Solid Tumor Drug Regions (Countries) Ranking by Market Size
2.5 Solid Tumor Drug Market Dynamics
2.5.1 Solid Tumor Drug Market Trends
2.5.2 Solid Tumor Drug Market Drivers
2.5.3 Solid Tumor Drug Market Challenges
2.5.4 Solid Tumor Drug Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Solid Tumor Drug Manufacturers by Sales (2017-2022)
3.1.1 Global Solid Tumor Drug Sales by Manufacturers (2017-2022)
3.1.2 Global Solid Tumor Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Solid Tumor Drug Sales in 2021
3.2 Global Top Manufacturers Solid Tumor Drug by Revenue
3.2.1 Global Solid Tumor Drug Revenue by Manufacturers (2017-2022)
3.2.2 Top Solid Tumor Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Solid Tumor Drug Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Solid Tumor Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2021)
3.4 Global Solid Tumor Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Solid Tumor Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Solid Tumor Drug Market
3.7 Key Manufacturers Solid Tumor Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Solid Tumor Drug Market Size by Type
4.1 Global Solid Tumor Drug Historic Market Review by Type (2017-2022)
4.1.1 Global Solid Tumor Drug Sales Market Share by Type (2017-2022)
4.1.2 Global Solid Tumor Drug Revenue Market Share by Type (2017-2022)
4.1.3 Solid Tumor Drug Price by Type (2017-2022)
4.2 Global Solid Tumor Drug Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Solid Tumor Drug Sales Forecast by Type (2023-2028)
4.2.2 Global Solid Tumor Drug Revenue Forecast by Type (2023-2028)
4.2.3 Solid Tumor Drug Price Forecast by Type (2023-2028)
5 Global Solid Tumor Drug Market Size by Application
5.1 Global Solid Tumor Drug Historic Market Review by Application (2017-2022)
5.1.1 Global Solid Tumor Drug Sales Market Share by Application (2017-2022)
5.1.2 Global Solid Tumor Drug Revenue Market Share by Application (2017-2022)
5.1.3 Solid Tumor Drug Price by Application (2017-2022)
5.2 Global Solid Tumor Drug Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Solid Tumor Drug Sales Forecast by Application (2023-2028)
5.2.2 Global Solid Tumor Drug Revenue Forecast by Application (2023-2028)
5.2.3 Solid Tumor Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Solid Tumor Drug Sales Breakdown by Company
6.1.1 North America Solid Tumor Drug Sales by Company (2017-2022)
6.1.2 North America Solid Tumor Drug Revenue by Company (2017-2022)
6.2 North America Solid Tumor Drug Market Size by Type
6.2.1 North America Solid Tumor Drug Sales by Type (2017-2028)
6.2.2 North America Solid Tumor Drug Revenue by Type (2017-2028)
6.3 North America Solid Tumor Drug Market Size by Application
6.3.1 North America Solid Tumor Drug Sales by Application (2017-2028)
6.3.2 North America Solid Tumor Drug Revenue by Application (2017-2028)
6.4 North America Solid Tumor Drug Market Size by Country
6.4.1 North America Solid Tumor Drug Sales by Country (2017-2028)
6.4.2 North America Solid Tumor Drug Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Solid Tumor Drug Sales Breakdown by Company
7.1.1 Europe Solid Tumor Drug Sales by Company (2017-2022)
7.1.2 Europe Solid Tumor Drug Revenue by Company (2017-2022)
7.2 Europe Solid Tumor Drug Market Size by Type
7.2.1 Europe Solid Tumor Drug Sales by Type (2017-2028)
7.2.2 Europe Solid Tumor Drug Revenue by Type (2017-2028)
7.3 Europe Solid Tumor Drug Market Size by Application
7.3.1 Europe Solid Tumor Drug Sales by Application (2017-2028)
7.3.2 Europe Solid Tumor Drug Revenue by Application (2017-2028)
7.4 Europe Solid Tumor Drug Market Size by Country
7.4.1 Europe Solid Tumor Drug Sales by Country (2017-2028)
7.4.2 Europe Solid Tumor Drug Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Solid Tumor Drug Sales Breakdown by Company
8.1.1 Asia Pacific Solid Tumor Drug Sales by Company (2017-2022)
8.1.2 Asia Pacific Solid Tumor Drug Revenue by Company (2017-2022)
8.2 Asia Pacific Solid Tumor Drug Market Size by Type
8.2.1 Asia Pacific Solid Tumor Drug Sales by Type (2017-2028)
8.2.2 Asia Pacific Solid Tumor Drug Revenue by Type (2017-2028)
8.3 Asia Pacific Solid Tumor Drug Market Size by Application
8.3.1 Asia Pacific Solid Tumor Drug Sales by Application (2017-2028)
8.3.2 Asia Pacific Solid Tumor Drug Revenue by Application (2017-2028)
8.4 Asia Pacific Solid Tumor Drug Market Size by Region
8.4.1 Asia Pacific Solid Tumor Drug Sales by Region
8.4.2 Asia Pacific Solid Tumor Drug Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Solid Tumor Drug Sales Breakdown by Company
9.1.1 Latin America Solid Tumor Drug Sales by Company (2017-2022)
9.1.2 Latin America Solid Tumor Drug Revenue by Company (2017-2022)
9.2 Latin America Solid Tumor Drug Market Size by Type
9.2.1 Latin America Solid Tumor Drug Sales by Type (2017-2028)
9.2.2 Latin America Solid Tumor Drug Revenue by Type (2017-2028)
9.3 Latin America Solid Tumor Drug Market Size by Application
9.3.1 Latin America Solid Tumor Drug Sales by Application (2017-2028)
9.3.2 Latin America Solid Tumor Drug Revenue by Application (2017-2028)
9.4 Latin America Solid Tumor Drug Market Size by Country
9.4.1 Latin America Solid Tumor Drug Sales by Country (2017-2028)
9.4.2 Latin America Solid Tumor Drug Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Solid Tumor Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Solid Tumor Drug Sales by Company (2017-2022)
10.1.2 Middle East and Africa Solid Tumor Drug Revenue by Company (2017-2022)
10.2 Middle East and Africa Solid Tumor Drug Market Size by Type
10.2.1 Middle East and Africa Solid Tumor Drug Sales by Type (2017-2028)
10.2.2 Middle East and Africa Solid Tumor Drug Revenue by Type (2017-2028)
10.3 Middle East and Africa Solid Tumor Drug Market Size by Application
10.3.1 Middle East and Africa Solid Tumor Drug Sales by Application (2017-2028)
10.3.2 Middle East and Africa Solid Tumor Drug Revenue by Application (2017-2028)
10.4 Middle East and Africa Solid Tumor Drug Market Size by Country
10.4.1 Middle East and Africa Solid Tumor Drug Sales by Country (2017-2028)
10.4.2 Middle East and Africa Solid Tumor Drug Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 AstraZeneca Solid Tumor Drug Products and Services
11.1.5 AstraZeneca Solid Tumor Drug SWOT Analysis
11.1.6 AstraZeneca Recent Developments
11.2 Biogen
11.2.1 Biogen Corporation Information
11.2.2 Biogen Overview
11.2.3 Biogen Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Biogen Solid Tumor Drug Products and Services
11.2.5 Biogen Solid Tumor Drug SWOT Analysis
11.2.6 Biogen Recent Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Overview
11.3.3 Baxter Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Baxter Solid Tumor Drug Products and Services
11.3.5 Baxter Solid Tumor Drug SWOT Analysis
11.3.6 Baxter Recent Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Corporation Information
11.4.2 Celgene Corporation Overview
11.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Celgene Corporation Solid Tumor Drug Products and Services
11.4.5 Celgene Corporation Solid Tumor Drug SWOT Analysis
11.4.6 Celgene Corporation Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Corporation Information
11.5.2 Abbott Laboratories Overview
11.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Abbott Laboratories Solid Tumor Drug Products and Services
11.5.5 Abbott Laboratories Solid Tumor Drug SWOT Analysis
11.5.6 Abbott Laboratories Recent Developments
11.6 Pfizer Inc
11.6.1 Pfizer Inc Corporation Information
11.6.2 Pfizer Inc Overview
11.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Pfizer Inc Solid Tumor Drug Products and Services
11.6.5 Pfizer Inc Solid Tumor Drug SWOT Analysis
11.6.6 Pfizer Inc Recent Developments
11.7 Amgen Limited & Amgen Ireland Limited
11.7.1 Amgen Limited & Amgen Ireland Limited Corporation Information
11.7.2 Amgen Limited & Amgen Ireland Limited Overview
11.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Products and Services
11.7.5 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug SWOT Analysis
11.7.6 Amgen Limited & Amgen Ireland Limited Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Corporation Information
11.8.2 Bristol-Myers Squibb Company Overview
11.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Bristol-Myers Squibb Company Solid Tumor Drug Products and Services
11.8.5 Bristol-Myers Squibb Company Solid Tumor Drug SWOT Analysis
11.8.6 Bristol-Myers Squibb Company Recent Developments
11.9 GlaxoSmithKline plc.
11.9.1 GlaxoSmithKline plc. Corporation Information
11.9.2 GlaxoSmithKline plc. Overview
11.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 GlaxoSmithKline plc. Solid Tumor Drug Products and Services
11.9.5 GlaxoSmithKline plc. Solid Tumor Drug SWOT Analysis
11.9.6 GlaxoSmithKline plc. Recent Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.10.2 F. Hoffmann-La Roche Ltd. Overview
11.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Products and Services
11.10.5 F. Hoffmann-La Roche Ltd. Solid Tumor Drug SWOT Analysis
11.10.6 F. Hoffmann-La Roche Ltd. Recent Developments
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Corporation Information
11.11.2 Eli Lilly and Company Overview
11.11.3 Eli Lilly and Company Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Eli Lilly and Company Solid Tumor Drug Products and Services
11.11.5 Eli Lilly and Company Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Corporation Information
11.12.2 Johnson & Johnson Overview
11.12.3 Johnson & Johnson Solid Tumor Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Johnson & Johnson Solid Tumor Drug Products and Services
11.12.5 Johnson & Johnson Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Solid Tumor Drug Value Chain Analysis
12.2 Solid Tumor Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Solid Tumor Drug Production Mode & Process
12.4 Solid Tumor Drug Sales and Marketing
12.4.1 Solid Tumor Drug Sales Channels
12.4.2 Solid Tumor Drug Distributors
12.5 Solid Tumor Drug Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Solid Tumor Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Solid Tumor Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Small Molecules
Table 3. Major Manufacturers of Biologics
Table 4. Global Solid Tumor Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Solid Tumor Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Solid Tumor Drug Sales by Region (2017-2022) & (K MT)
Table 7. Global Solid Tumor Drug Sales Market Share by Region (2017-2022)
Table 8. Global Solid Tumor Drug Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Solid Tumor Drug Revenue Market Share by Region (2017-2022)
Table 10. Global Solid Tumor Drug Sales Forecast by Region (2023-2028) & (K MT)
Table 11. Global Solid Tumor Drug Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Solid Tumor Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Solid Tumor Drug Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Solid Tumor Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Solid Tumor Drug Market Trends
Table 16. Solid Tumor Drug Market Drivers
Table 17. Solid Tumor Drug Market Challenges
Table 18. Solid Tumor Drug Market Restraints
Table 19. Global Solid Tumor Drug Sales by Manufacturers (2017-2022) & (K MT)
Table 20. Global Solid Tumor Drug Sales Share by Manufacturers (2017-2022)
Table 21. Global Solid Tumor Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Solid Tumor Drug Manufacturers by Revenue (US$ Million) in 2021
Table 23. Solid Tumor Drug Revenue Share by Manufacturers (2017-2022)
Table 24. Global Solid Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2021)
Table 26. Key Manufacturers Solid Tumor Drug Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 27. Key Manufacturers Solid Tumor Drug Plants/Factories Distribution
Table 28. Key Manufacturers Solid Tumor Drug Area Served
Table 29. Date of Key Manufacturers Enter into Solid Tumor Drug Market
Table 30. Key Manufacturers Solid Tumor Drug Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Solid Tumor Drug Sales (K MT) by Type (2017-2022)
Table 33. Global Solid Tumor Drug Sales Share by Type (2017-2022)
Table 34. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Solid Tumor Drug Price (K MT) by Type (2017-2022)
Table 36. Global Solid Tumor Drug Sales (K MT) by Type (2023-2028)
Table 37. Global Solid Tumor Drug Sales Share by Type (2023-2028)
Table 38. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Solid Tumor Drug Revenue Share by Type (2023-2028)
Table 40. Global Solid Tumor Drug Price (K MT) by Type (2023-2028)
Table 41. Global Solid Tumor Drug Sales (K MT) by Application (2017-2022)
Table 42. Global Solid Tumor Drug Sales Share by Application (2017-2022)
Table 43. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Solid Tumor Drug Price (K MT) by Application (2017-2022)
Table 45. Global Solid Tumor Drug Sales (K MT) by Application (2023-2028)
Table 46. Global Solid Tumor Drug Sales Share by Application (2023-2028)
Table 47. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Solid Tumor Drug Revenue Share by Application (2023-2028)
Table 49. Global Solid Tumor Drug Price (K MT) by Application (2023-2028)
Table 50. North America Solid Tumor Drug Sales by Company (2017-2022) & (K MT)
Table 51. North America Solid Tumor Drug Sales Market Share by Company (2017-2022)
Table 52. North America Solid Tumor Drug Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Solid Tumor Drug Revenue Market Share by Company (2017-2022)
Table 54. North America Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 55. North America Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 56. North America Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 59. North America Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 60. North America Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 63. North America Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 64. North America Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Solid Tumor Drug Sales by Company (2017-2022) & (K MT)
Table 67. Europe Solid Tumor Drug Sales Market Share by Company (2017-2022)
Table 68. Europe Solid Tumor Drug Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Solid Tumor Drug Revenue Market Share by Company (2017-2022)
Table 70. Europe Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 71. Europe Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 72. Europe Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 75. Europe Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 76. Europe Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 79. Europe Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 80. Europe Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Solid Tumor Drug Sales by Company (2017-2022) & (K MT)
Table 83. Asia Pacific Solid Tumor Drug Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Solid Tumor Drug Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Solid Tumor Drug Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 87. Asia Pacific Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 88. Asia Pacific Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 91. Asia Pacific Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 92. Asia Pacific Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Solid Tumor Drug Sales by Region (2017-2022) & (K MT)
Table 95. Asia Pacific Solid Tumor Drug Sales by Region (2023-2028) & (K MT)
Table 96. Asia Pacific Solid Tumor Drug Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Solid Tumor Drug Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Solid Tumor Drug Sales by Company (2017-2022) & (K MT)
Table 99. Latin America Solid Tumor Drug Sales Market Share by Company (2017-2022)
Table 100. Latin America Solid Tumor Drug Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Solid Tumor Drug Revenue Market Share by Company (2017-2022)
Table 102. Latin America Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 103. Latin America Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 104. Latin America Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 107. Latin America Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 108. Latin America Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 111. Latin America Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 112. Latin America Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Solid Tumor Drug Sales by Company (2017-2022) & (K MT)
Table 115. Middle East and Africa Solid Tumor Drug Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Solid Tumor Drug Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Solid Tumor Drug Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 119. Middle East and Africa Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 120. Middle East and Africa Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 123. Middle East and Africa Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 124. Middle East and Africa Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 127. Middle East and Africa Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 128. Middle East and Africa Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 130. AstraZeneca Corporation Information
Table 131. AstraZeneca Description and Overview
Table 132. AstraZeneca Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 133. AstraZeneca Solid Tumor Drug Product and Services
Table 134. AstraZeneca Solid Tumor Drug SWOT Analysis
Table 135. AstraZeneca Recent Developments
Table 136. Biogen Corporation Information
Table 137. Biogen Description and Overview
Table 138. Biogen Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 139. Biogen Solid Tumor Drug Product and Services
Table 140. Biogen Solid Tumor Drug SWOT Analysis
Table 141. Biogen Recent Developments
Table 142. Baxter Corporation Information
Table 143. Baxter Description and Overview
Table 144. Baxter Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 145. Baxter Solid Tumor Drug Product and Services
Table 146. Baxter Solid Tumor Drug SWOT Analysis
Table 147. Baxter Recent Developments
Table 148. Celgene Corporation Corporation Information
Table 149. Celgene Corporation Description and Overview
Table 150. Celgene Corporation Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 151. Celgene Corporation Solid Tumor Drug Product and Services
Table 152. Celgene Corporation Solid Tumor Drug SWOT Analysis
Table 153. Celgene Corporation Recent Developments
Table 154. Abbott Laboratories Corporation Information
Table 155. Abbott Laboratories Description and Overview
Table 156. Abbott Laboratories Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 157. Abbott Laboratories Solid Tumor Drug Product and Services
Table 158. Abbott Laboratories Solid Tumor Drug SWOT Analysis
Table 159. Abbott Laboratories Recent Developments
Table 160. Pfizer Inc Corporation Information
Table 161. Pfizer Inc Description and Overview
Table 162. Pfizer Inc Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 163. Pfizer Inc Solid Tumor Drug Product and Services
Table 164. Pfizer Inc Solid Tumor Drug SWOT Analysis
Table 165. Pfizer Inc Recent Developments
Table 166. Amgen Limited & Amgen Ireland Limited Corporation Information
Table 167. Amgen Limited & Amgen Ireland Limited Description and Overview
Table 168. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 169. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product and Services
Table 170. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug SWOT Analysis
Table 171. Amgen Limited & Amgen Ireland Limited Recent Developments
Table 172. Bristol-Myers Squibb Company Corporation Information
Table 173. Bristol-Myers Squibb Company Description and Overview
Table 174. Bristol-Myers Squibb Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 175. Bristol-Myers Squibb Company Solid Tumor Drug Product and Services
Table 176. Bristol-Myers Squibb Company Solid Tumor Drug SWOT Analysis
Table 177. Bristol-Myers Squibb Company Recent Developments
Table 178. GlaxoSmithKline plc. Corporation Information
Table 179. GlaxoSmithKline plc. Description and Overview
Table 180. GlaxoSmithKline plc. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 181. GlaxoSmithKline plc. Solid Tumor Drug Product and Services
Table 182. GlaxoSmithKline plc. Solid Tumor Drug SWOT Analysis
Table 183. GlaxoSmithKline plc. Recent Developments
Table 184. F. Hoffmann-La Roche Ltd. Corporation Information
Table 185. F. Hoffmann-La Roche Ltd. Description and Overview
Table 186. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 187. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product and Services
Table 188. F. Hoffmann-La Roche Ltd. Solid Tumor Drug SWOT Analysis
Table 189. F. Hoffmann-La Roche Ltd. Recent Developments
Table 190. Eli Lilly and Company Corporation Information
Table 191. Eli Lilly and Company Description and Overview
Table 192. Eli Lilly and Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 193. Eli Lilly and Company Solid Tumor Drug Product and Services
Table 194. Eli Lilly and Company Recent Developments
Table 195. Johnson & Johnson Corporation Information
Table 196. Johnson & Johnson Description and Overview
Table 197. Johnson & Johnson Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 198. Johnson & Johnson Solid Tumor Drug Product and Services
Table 199. Johnson & Johnson Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Solid Tumor Drug Distributors List
Table 203. Solid Tumor Drug Customers List
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Solid Tumor Drug Product Picture
Figure 2. Global Solid Tumor Drug Sales Market Share by Type in 2021 & 2028
Figure 3. Small Molecules Product Picture
Figure 4. Biologics Product Picture
Figure 5. Global Solid Tumor Drug Sales Market Share by Application in 2021 & 2028
Figure 6. Oncology Use Case
Figure 7. Neurology Use Case
Figure 8. Radiology Use Case
Figure 9. Others Use Case
Figure 10. Solid Tumor Drug Report Years Considered
Figure 11. Global Solid Tumor Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Solid Tumor Drug Market Size 2017-2028 (US$ Million)
Figure 13. Global Solid Tumor Drug Sales (2017-2022) & (K MT)
Figure 14. Global Solid Tumor Drug Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Solid Tumor Drug Sales Market Share by Region (2017-2022)
Figure 16. Global Solid Tumor Drug Sales Market Share by Region in 2021
Figure 17. Global Solid Tumor Drug Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Solid Tumor Drug Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Solid Tumor Drug Sales in 2021
Figure 20. Solid Tumor Drug Revenue Share by Manufacturers in 2021
Figure 21. Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Solid Tumor Drug Revenue Share by Type (2017-2022)
Figure 23. Global Solid Tumor Drug Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Solid Tumor Drug Revenue Share by Application (2017-2022)
Figure 25. Global Solid Tumor Drug Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 27. North America Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 28. North America Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 29. North America Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 30. North America Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 31. North America Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 32. U.S. Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 33. Canada Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 34. Europe Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 35. Europe Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 36. Europe Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 37. Europe Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 38. Europe Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 39. Europe Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 40. Germany Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 41. France Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 42. U.K. Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Italy Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 44. Russia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 45. Asia Pacific Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 46. Asia Pacific Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 47. Asia Pacific Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 48. Asia Pacific Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 49. Asia Pacific Solid Tumor Drug Sales Share by Region (2017-2028)
Figure 50. Asia Pacific Solid Tumor Drug Revenue Share by Region (2017-2028)
Figure 51. China Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Japan Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 53. South Korea Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 54. India Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Australia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 56. China Taiwan Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 57. Indonesia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 58. Thailand Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 59. Malaysia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 60. Latin America Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 61. Latin America Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 62. Latin America Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 63. Latin America Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 64. Latin America Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 65. Latin America Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 66. Mexico Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Brazil Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Argentina Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Middle East and Africa Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 74. Middle East and Africa Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 75. Turkey Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 77. UAE Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Solid Tumor Drug Value Chain
Figure 79. Solid Tumor Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Keyplayers in Global Solid Tumor Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
AstraZenecaBiogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
Request Sample
Request Discount
